PRESUNA – Phase 1 Market Potential and Adoption Strategy

Chronic diseases including congestive heart failure are a huge burden on the healthcare system and lead to a high degree of patient suffering. Ultrasound-guided therapies (UGT) hold a lot of promise to reduce chronic disease-associated hospital admissions and complications, however currently the use of UGT requires a systems-based support which may be too complex and costly for routine clinical use and widespread adoption. Further, widespread clinical use of UGTs is hampered by the scarcity of ultrasound-competent clinicians and the accessibility of point of care ultrasound (POCUS) experts available to train interested clinicians. At PRESUNA, we have developed a non-invasive, reliable and affordable way to quantify the ultrasound findings of diagnosed chronic disease over time. A secondary but equally important component of our business is our ultrasound competency training which will allow POCUS experts to train POCUS newcomers and assess ongoing competency. We are in late-stage development of our competency training and gearing up for market entry. Through this project, the intern (Ean) will assist with the critical commercialization components of our competency training including market segmentation, sizing and marketing. Ean will also lead the creation of PRESUNA’s Knowledge Base to enhance global POCUS education, in turn helping to accelerate POCUS adoption and ultimately the usage of UGTs. Further, Ean will help to establish PRESUNA’s public image and help us to grow our clinical network as we prepare for market entry. This project will be hugely beneficial for PRESUNA in establishing our marketing and commercialization strategy.

Faculty Supervisor:

Irene Ma

Student:

Partner:

PRESUNA

Discipline:

Business

Sector:

Health and Related Sciences & Technology

University:

University of Calgary

Program: